Oculus Innovative Wt (OCLSW) 0.24 $OCLSW Oculus

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Oculus Innovative Wt (OCLSW) 0.24 $OCLSW

Oculus Innovative Sciences to Present at the Third Annual Growth Capital Expo MicroCap Investor Conference in Las Vegas
GlobeNewswire - Wed Apr 27, 3:05AM CDT
Oculus Innovative Sciences, Inc. (NASDAQ:OCLS) (NASDAQ:OCLSW), a specialty pharmaceutical company that develops and markets solutions for the treatment of dermatological conditions and advanced tissue care, today announced that Jim Schutz, the company's CEO, will present a corporate overview and business update at the Third Annual Growth Capital Expo MicroCap Investor Conference, to be held on May 3-5, 2016 at Caesars Palace in Las Vegas. The Oculus presentation is scheduled on Wednesday, May 4, 2016, at 10:00 am PDT, with a breakout session to immediately follow.
OCLSW: 0.24 (-0.02), OCLS: 4.08 (-0.03)

Oculus Innovative Sciences Receives European Approval to Market Sinudox(TM) Indicated for Use in Nasal Irrigation
GlobeNewswire - Wed Apr 13, 3:05AM CDT
Oculus Innovative Sciences, Inc. (NASDAQ:OCLS) (NASDAQ:OCLSW), a specialty pharmaceutical company that develops and markets solutions for the treatment of dermatological conditions and advanced tissue care, today announced the issuance of a new CE Mark in Europe for Microcyn(R)-based Sinudox(TM) solution, a formulation intended for nasal irrigation including the moistening of cuts, abrasions and lacerations located in the nasal cavity.
OCLSW: 0.24 (-0.02), OCLS: 4.08 (-0.03)

Oculus Innovative Sciences Reports Financial Results for the Second Quarter of Fiscal Year 2016
GlobeNewswire - Thu Nov 05, 3:05PM CST
Total Revenue of $4.1 Million Increased 24%--Led by 64% Increase in Product Revenue--Driven by Growth in U.S. Dermatology Sales
OCLSW: 0.24 (-0.02), OCLS: 4.08 (-0.03)

Oculus Innovative Sciences Announces Fiscal Second Quarter 2016 Financial Results and Conference Call
GlobeNewswire - Thu Oct 22, 5:05AM CDT
Oculus Innovative Sciences, Inc. (NASDAQ:OCLS), tradable warrants (NASDAQ:OCLSW) today announced that the financial results for its fiscal second quarter 2016, ended September 30, 2015, will be released after the U.S. markets close on November 5, 2015. The earnings release will be followed by a conference call at 1:30 p.m. PT on November 5, 2015, to discuss fiscal second quarter results.
OCLSW: 0.24 (-0.02), OCLS: 4.08 (-0.03)

Oculus Innovative Sciences Announces Preliminary Results for Its 2015 Annual Meeting of Stockholders
GlobeNewswire - Fri Sep 11, 5:30PM CDT
Oculus Innovative Sciences, Inc. (NASDAQ:OCLS), tradeable warrants (NASDAQ:OCLSW) today announced that the four proposals presented in its annual meeting proxy statement have, through September 10, 2015, received the affirmative vote of more than a majority of Oculus' shares of common stock represented or present at the 2015 annual meeting of stockholders.
OCLSW: 0.24 (-0.02), OCLS: 4.08 (-0.03)

Oculus Innovative Sciences Regains Compliance With NASDAQ Minimum Bid Price Rule
GlobeNewswire - Thu Jun 18, 5:00AM CDT
Oculus Innovative Sciences, Inc. (Nasdaq:OCLS) (Nasdaq:OCLSW), a specialty pharmaceutical company that develops and markets solutions for the treatment of dermatological conditions and advanced tissue care, today announced that it received a formal determination letter from The NASDAQ Stock Market LLC ("NASDAQ" notifying the company that it is now compliant with the minimum bid price requirement for continued listing on the NASDAQ Capital Market and is no longer subject to delisting at this time. The NASDAQ staff has determined that for the 10 consecutive business days, from June 3, 2015, to June 16, 2015, the closing bid price of the company's common stock has been at $1.00 per share or greater.
OCLSW: 0.24 (-0.02), OCLS: 4.08 (-0.03)

Oculus Innovative Sciences Announces Sale of 1.65 Million Shares of Ruthigen Stock for $4.5 Million in Non-Dilutive Funding
GlobeNewswire - Tue Jun 16, 5:00AM CDT
-- Ruthigen/Pulmatrix merger closed on June 15, 2015, enabling Oculus' sale of Ruthigen shares to close on or before June 18, 2015
OCLSW: 0.24 (-0.02), OCLS: 4.08 (-0.03)

Oculus Innovative Sciences concludes public offering of common stock and warrants
M2 - Wed Jan 28, 4:21AM CST
Pharmaceutical company Oculus Innovative Sciences (Nasdaq:OCLS) (Nasdaq:OCLSW) disclosed on Tuesday that its has raised gross proceeds from its public offering, including the underwriters' partial exercise of the over-allotment option, of approximately USD6.3m.
OCLSW: 0.24 (-0.02), OCLS: 4.08 (-0.03)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

SPECS Framework: Rethinking Career Growth Strategies

Updated Category News Views 61

An Evolving Workplace Demands Evolving Strategies Look, careers ain't what they used to be—and they shouldn't be. Today’s world is flipping the script on how we work, and Dr. Brandi R. Muñoz is rewriting the book on career development with her SPECS framework. The guy clinging to his outdated Rolodex for advice isn't gonna cut it anymore. "Who Are Your SPECS?...

Continue Reading
Bird-X Welcomes Doolittle to Elevate Sales Strategy

Updated Category News Views 105

Change in Flight: Bird-X Eyes Strategic Growth Well, here's one that might spread its wings wide. Emanuel Doolittle has joined Bird-X, Inc. as Director of Sales and Business Development. Now, let's not beat around the bush — Bird-X isn't a name you'd see thrown around daily stock talks, but it's stirring up interest in the pest control sector without question. Why...

Continue Reading
Goodal Skincare Capitalizes on K-Beauty Craze at Costco

Updated Category News Views 38

A Venture into American Retail Goodal, the darling of Korea's skincare scene, is staking its claim at Costco. This is no small feat, my friends. We're talkin' about a brand that's carved out a sweet niche with its Green Tangerine line. Now it's hitching its wagon to one of America's retail behemoths, known for its unique knack in beauty products. From Olive Young to...

Continue Reading
DUPR Teams Up with InBody to Elevate Pickleball Fitness

Updated Category News Views 0

Well, here's a twist in the pickleball world—DUPR and InBody have struck a deal to bring top-notch body composition tech to the ever-expanding universe of pickleballers. They're merging power players from two different worlds to tap into your performance on the court and your wellness off it. Maybe I'm just jaded from too many marketing pitches, but this one could...

Continue Reading
PG&E's $2B Delay: A Blame Game or Real Crisis?

Updated Category News Views 163

Just when you think the circus of energy utilities couldn't get any more outlandish, PG&E grabs the spotlight once more. Picture this: they've got the megaphone out, threatening to put the brakes on $2 billion in crucial infrastructure investments. Twenty-five thousand customers left hanging, just waiting for their lights to come on. As if that's not enough, PG&E is also...

Continue Reading
Telemed Sites Need Solid Payment Systems with AI

Updated Category News Views 54

Brace for Impact: Payment Processors in Telehealth A new era is brewing in telehealth, with AI coding tools making website creation a breeze for healthcare folks. But here's the kicker: accepting credit cards is not as easy as setting up a snazzy booking page. Take it from Organic Payment Gateways in good ol' Scarborough, Maine, who've decided to toss their hat into this...

Continue Reading
Luxury Vinyl Tiles Market Set for Steady Growth to 2031

Updated Category News Views 69

Luxury Vinyl Tiles: A Market on the Rise Well, folks, the flooring game is picking up steam, and luxury vinyl tiles (LVT) are in the spotlight. With consumers and businesses all looking for something durable yet easy on the eyes and wallet, LVT is answering the call. MarketsandMarkets™ reports that this sector is expected to balloon from USD 18.22 billion in 2026 to USD...

Continue Reading
Bright Minds in Hot Water: Investigation Shakes Investors

Updated Category News Views 91

FDA Throws Wrench Into Bright Minds' Plans This ain't the first time a biotech company's dream has hit the skids, but Bright Minds Biosciences (NASDAQ:DRUG) found themselves in the meat grinder when the FDA threw their epilepsy trial plans under the bus. The partial clinical hold wasn't a gentle slap on the wrist, but a gut punch driven by mouse toxicity findings and...

Continue Reading
ESAC Redefines Entertainment Centers, Eyes 2027 Trends

Updated Category News Views 107

A New Era for Family Entertainment Centers Forget the traditional FEC with its solitary rides; the future's all about constructing social destinations that blend immersive storytelling and hybrid offerings. Elephant Sculpture Art Co., Ltd. (ESAC) is at the forefront, drawing from their Shanghai WUNPARK project to reimagine the design of these amusement hubs. Set to engage...

Continue Reading
AMETEK Surpasses Q3 2026 Expectations, Raises Outlook

Updated Category News Views 11

A Banner Quarter for AMETEK Holy smokes, AMETEK has thrown down some numbers for the third quarter of 2026 that would make any seasoned trader sit up and take notice. We’re talking record-breaking across the board: $2.22 billion in sales, marking a whopping 17% increase over last year. Now, that's not just growth—that's rocket fuel. Earnings per share rocketed up with...

Continue Reading

Top 5 Most Recently Viewed Articles

ThredUp Reports Q3 2024 Financial Results; Outlook Brightens

Updated Category News Views 55

ThredUp Financial Results for the Third Quarter In the recently concluded third quarter, ThredUp Inc. (NASDAQ: TDUP) reported total revenue of $73 million, marking an 11% decline year-over-year. This decline stems from various market factors influencing the resale industry. Revenue Breakdown and Margins The U.S. market alone contributed $61.5 million to the overall...

Continue Reading
Tesla Faces Sales Challenges in Europe Amidst Controversies

Updated Category News Views 372

Tesla's Declining Sales in Key European Markets Tesla Inc (NASDAQ: TSLA) is facing significant sales declines in several European countries as reported in early 2025. These drops, drastic in some cases, seem to be a reflection of growing consumer dissatisfaction linked to CEO Elon Musk's heightened political involvement. The Impact of Elon Musk's Political Engagement As...

Continue Reading
Dermata Therapeutics Faces Market Challenges with Stock at $1.28

Updated Category News Views 48

Dermata Therapeutics and its Recent Stock Performance In a highly competitive market landscape, Dermata Therapeutics Inc. (DRMA) has experienced a significant decline in stock value, recently hitting a 52-week low of $1.28. As a biotechnology company specializing in dermatological treatments, Dermata has encountered considerable challenges over the past year, resulting in...

Continue Reading
Indonesia Advances in Critical Minerals for EV & Green Technologies

Updated Category News Views 138

Indonesia's Commitment to the Critical Minerals Industry Fastmarkets proudly reveals an important partnership with the Ministry of Investment and Downstream Industry of Indonesia. This collaboration highlights Indonesia's strategy to boost its role in the global supply chain of critical minerals, aiming to support a sustainable economy centered around clean energy...

Continue Reading
Cox Automotive Revolutionizes Vehicle Appraisal with AI

Updated Category News Views 270

Cox Automotive's Innovative Integration with UVeye Cox Automotive is at the forefront of automotive technology, consistently advancing how dealerships operate. In a recent development, they have integrated their distinctive vAuto platform with UVeye. This integration marks a significant milestone in improving vehicle appraisal processes, allowing for greater efficiency...

Continue Reading